Month: June 2022

VANCOUVER, Wash., June 28, 2022 (GLOBE NEWSWIRE) — Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage biotechnology company developing medicines for metabolic and immunological diseases through its proprietary approach to synthetic biology, announced today it will participate at the National PKU Alliance’s (NPKUA) biennial conference July 7-10, 2022 in Vancouver, Washington. As an event sponsor, Synlogic has been invited to present during the session “What’s New in PKU? (Emerging Therapies, Research, Foods & Beyond).” In addition, the team will share data on dietary protein intake in PKU patients during a poster presentation. Presentation:Title: Transforming Medicine through Synthetic Biology Presenter: Dr. Marja Puurunen, MD, Ph.D, Therapeutic Area Lead, Executive Medical Director Date and Time: Friday, July 8, 2022; 3:30...

ONO to Contribute Novel Binding Domains for a Second Solid Tumor Antigen to the Collaboration Expanded Partnership Enables Development of both CAR NK and CAR T-cell Collaboration Candidates for Solid Tumors SAN DIEGO, June 28, 2022 (GLOBE NEWSWIRE) — Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for patients with cancer, today announced that it has expanded its off-the-shelf, iPSC-derived, cell-based cancer immunotherapy collaboration with ONO Pharmaceutical Co., Ltd. (ONO) to include the development of chimeric antigen receptor (CAR) NK cell collaboration candidates. In addition, as part of the collaboration’s expansion, ONO will contribute novel binding domains targeting a second solid tumor antigen. Under the original Collaboration...

PARIS, June 28, 2022 (GLOBE NEWSWIRE) — Exela Technologies, Inc. (“Exela”) (NASDAQ: XELA, XELAP), today announced a contract with L’Assurance Maladie Caisse Nationale (“Cnam”), the French National Insurance Fund, utilizing Exela’s PCH Global platform to speed up the National Agency’s digital transformation. While the initial total contract value (“TCV”) is $2.5 million, the 4-year contract has the potential to grow to over $4.5 million over this period. Initially, the solution will deploy Exela’s cutting-edge Raptor and Intelliscan XDS scanners as well as a full OCR application across multiple sites as part of Exela ITPS (Information and Transaction Processing Solutions) segment. The online classification and extended sorting capacity will handle a wide range of document types and the initial deployment will be rolled out to two...

NEW YORK, June 28, 2022 (GLOBE NEWSWIRE) — OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for 12,000 U.S. and international securities, today announced Lundin Gold Inc. (TSX: LUG; Nasdaq Stockholm: LUG; OTCQX: LUGDF), a Canadian mining company, has qualified to trade on the OTCQX® Best Market. Lundin Gold Inc. upgraded to OTCQX from the Pink® market. Lundin Gold Inc. begins trading today on OTCQX under the symbol “LUGDF.” U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on www.otcmarkets.com. Upgrading to the OTCQX Market is an important step for companies seeking to provide transparent trading for their U.S. investors. For companies listed on a qualified international exchange, streamlined market standards enable them to utilize their home market reporting to...

NEW YORK, June 28, 2022 (GLOBE NEWSWIRE) — OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Collective Mining Ltd (TSX-V: CNL; OTCQX: CNLMF), an exploration and development company focused on identifying and exploring prospective mineral projects in South America, has qualified to trade on the OTCQX® Best Market. Collective Mining Ltd upgraded to OTCQX from the Pink® market. Collective Mining Ltd begins trading today on OTCQX under the symbol “CNLMF.” U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on www.otcmarkets.com. Upgrading to the OTCQX Market is an important step for companies seeking to provide transparent trading for their U.S. investors. For companies listed on a qualified international...

Figure 1: Tróia Target Plan Map, highlighting trench locations and assays. Figure 1: Tróia Target Plan Map, highlighting trench locations and assays.Figure 2: Photographs from trenching at the Tróia Target, highlighting chromitite reef horizons and chromite-rich ultramafics. Figure 2: Photographs from trenching at the Tróia Target, highlighting chromitite reef horizons and chromite-rich ultramafics.Figure 3a: Trench TR22TR02 cross section, Tróia Target, highlighting geology, assays, and proximal Trado® auger drilling. Figure 3a: Trench TR22TR02 cross section, Tróia Target, highlighting geology, assays, and proximal Trado® auger drilling.Figure 3b: Trench TR22CC01 cross section, Tróia Target, highlighting geology, assays, and proximal Trado® auger drilling. Figure 3b: Trench TR22CC01 cross section, Tróia Target, highlighting geology,...

TORONTO, June 28, 2022 (GLOBE NEWSWIRE) — First Quantum Minerals Ltd. (“First Quantum” or “the Company”) (TSX: FM) will release second quarter 2022 financial and operating results on Tuesday, July 26, 2022 after the close of the Toronto Stock Exchange. The Company will host a conference call and webcast to discuss the results on Wednesday, July 27, 2022 at 9:00 am (EDT). Conference call and webcast details:Toll-free North America: 1-800-319-4610Toll-free International: +1-604-638-5340Webcast: www.first-quantum.com A replay of the webcast will be available on the First Quantum website. For further information, visit our website at www.first-quantum.com or contact: Bonita To, Director, Investor Relations (416) 361-6400 Toll-free: 1 (888) 688-6577E-Mail: info@fqml.com